Sirio Pharma to Acquire Best Formulations
July 11, 2022, 8:58:13 AM
Sirio Pharma Co. Ltd. (Shantou, Guangdong, China) has acquired 80% of the equity of Best Formulations Inc. (City of Industry, CA, US). Best Formulations specializes in the contract manufacturing of softgels in North America, as well as the manufacturing and commercialization of vitamins, minerals, plant-based nutritional supplements and personal care products.
“This is a significant milestone in Sirio’s strategy to establish a global manufacturing footprint. By adding Best’s world-class North American manufacturing facilities to our established bases in Asia and Europe, the combined company will be able to better serve both our global and regional customers with local production everywhere they want to be,” said Doug Brown, managing director of Sirio Americas.
Best Formulation’s City of Industry complex will now serve as Sirio’s North American headquarters once the transaction is completed.
“Our entire team is very excited to join the Sirio family in a shared mission of providing our customers with world-class service and innovative products. This combination will allow us to grow our business faster with global resources and capabilities,” said Eugene Ung, CEO of Best Formulations.
- Nutritional Outlook -
About Collabrium Partners
Collabrium Partners is a Chinese leading independent investment banking firm focused on providing financial advisories on mergers & acquisitions, strategic planning, restructuring, private placement, independent opinions to corporations, financial institutions, public service agencies, and others.
For more information, please visit www.collabrium.com